Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients

被引:0
作者
Van Dalen, A
Favier, J
Baumgartner, L
Hasholzner, U
De Bruijn, H
Dobbler, D
Dombi, VH
Fink, D
Giai, M
McGing, P
Harlozinska, A
Kainz, C
Markowska, J
Molina, R
Sturgeon, C
Einarsson, R
机构
[1] Groene Hart Ziekenhuis, Gouda, Netherlands
[2] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany
[3] Univ Groningen Hosp, Lab Obst & Gyn, Groningen, Netherlands
[4] Univ Zurich Hosp, Dept Obstet & Gynecol, CH-8091 Zurich, Switzerland
[5] Univ Turin, Ist Gin & Obst, I-10124 Turin, Italy
[6] Mater Misericordiae Hosp, Dept Pathol, Dublin 7, Ireland
[7] Univ Med, Dept Tumor Immunol, Wroclaw, Poland
[8] Univ Vienna, Sch Med, Dept Gyn & Obst, Vienna, Austria
[9] Sch Med, Dept Oncol, Poznan, Poland
[10] Hosp Clin Prov, Clin Chem Lab, Barcelona, Spain
[11] Royal Infirm, Edinburgh, Midlothian, Scotland
[12] BEKI Diagnost, Bromma, Sweden
关键词
CA; 125; TPS; ovarian cancer; prognosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The analysis of survival data of patients with epithelial ovarian cancer proved that both CA 125 and TPS were good markers for clinical outcome prediction. Patients receiving chemotherapy were analyzed for 2-year overall survival (OS). Kaplan-Meier survival analysis showed highly significant differences in OS between patients with stage I+II (survival for 2 years 68%) and stage III+IV (survival for 2 years 33%; p=0.0008). CA 125 levels above or below 35 kU/I and TPS levels above or below 80 U/l after 3 chemotherapy courses were not significantly correlated with OS in stage I+II patients (p=0.06 respectively 0.07). However, in the subgroup of patients with stage III+IV the cut-off levels of CA 125 and TPS were excellent discriminators of OS: With CA 125 levels below the cut-off 52% of the patients survived, while with CA 125 levels above the cut-off only 13% survived (p<0.0001). With TPS levels below the cut-off 49% of the patients survived, while with levels above the cut-off only 19% of the patients survived (p<0.0001). In the subset of patients with CA 125 levels less than 35 kU/I after 3 chemotherapy courses (n=50) analysis of their TPS levels allowed further discrimination of the prognostic significance. With TPS levels below the cut-off 63% of the patients survived while 35% of the patients survived with TPS levels above the cut-off The sum value of CA 125 and TPS cut-off values (115) as discriminator correlated even better with survival rate: With levels below this sum value 63%, of the patients survived while this was only 17% with sum values above the summed cut-off level (p=0.0004). The extent to which the tumor was removed at operation also correlated with the 2 years survival rate. None of the patients with a staging laparotomy (n=10) showed a 2-years survival The difference in OS between patients with complete debulking and partial debulking was significant: OS 51% versus 23% (p=0.027). Prognosis was not significantly correlated with histological type.
引用
收藏
页码:2523 / 2526
页数:4
相关论文
共 6 条
[1]   PREDICTIVE VALUE OF THE COMBINATION OF SERUM MARKERS, CA125, CASA AND TPS IN OVARIAN-CANCER [J].
DEVINE, PL ;
MCGUCKIN, MA ;
QUIN, RJ ;
WARD, BG .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (03) :170-178
[2]  
KENEMANS P, 1988, Cancer Reviews, V11-12, P119
[3]  
MACKAY EV, 1992, GYNECOLOGIC ONCOLOGY
[4]  
Pietrzak K, 1997, 10TH INTERNATIONAL MEETING OF GYNAECOLOGICAL ONCOLOGY, P279
[5]  
VanDalen A, 1997, 10TH INTERNATIONAL MEETING OF GYNAECOLOGICAL ONCOLOGY, P291
[6]  
VANDALEN A, 1993, TPS COLLECTION SCI A